These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33617809)

  • 1. Economic Evaluation of an N-terminal Pro B-type Natriuretic Peptide-Supported Diagnostic Strategy Among Dyspneic Patients Suspected of Acute Heart Failure in the Emergency Department.
    Siebert U; Milev S; Zou D; Litkiewicz M; Gaggin HK; Tirapelle L; Masson S; Januzzi JL
    Am J Cardiol; 2021 May; 147():61-69. PubMed ID: 33617809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.
    Januzzi JL; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Rivers EJ; Walters EL; Gaggin HK;
    J Am Coll Cardiol; 2018 Mar; 71(11):1191-1200. PubMed ID: 29544601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department.
    Siebert U; Januzzi JL; Beinfeld MT; Cameron R; Gazelle GS
    Am J Cardiol; 2006 Sep; 98(6):800-5. PubMed ID: 16950189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy.
    Klemen P; Golub M; Grmec S
    Croat Med J; 2009 Apr; 50(2):133-42. PubMed ID: 19399946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea.
    Murray H; Cload B; Collier CP; Sivilotti ML
    CJEM; 2006 Jul; 8(4):251-8. PubMed ID: 17324304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study.
    Moe GW; Howlett J; Januzzi JL; Zowall H;
    Circulation; 2007 Jun; 115(24):3103-10. PubMed ID: 17548729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency thoracic ultrasound in the differentiation of the etiology of shortness of breath (ETUDES): sonographic B-lines and N-terminal pro-brain-type natriuretic peptide in diagnosing congestive heart failure.
    Liteplo AS; Marill KA; Villen T; Miller RM; Murray AF; Croft PE; Capp R; Noble VE
    Acad Emerg Med; 2009 Mar; 16(3):201-10. PubMed ID: 19183402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.
    Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M
    BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
    Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of N-terminal-proBNP in differentiating acute pulmonary embolism from heart failure in patients with acute dyspnea.
    Guo L; Li G; Wang Y; Liang H; Shan X; Zhang N; Wang M; Lin D; Zhu L
    Chin Med J (Engl); 2014; 127(16):2888-93. PubMed ID: 25131222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Chen AA; Tung R; Anwaruddin S; Baggish AL; Januzzi JL
    J Card Fail; 2006 Aug; 12(6):452-7. PubMed ID: 16911912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NT-proBNP testing on diagnostic certainty in patients admitted to the emergency department with possible heart failure.
    Robaei D; Koe L; Bais R; Gould I; Stewart T; Tofler GH
    Ann Clin Biochem; 2011 May; 48(Pt 3):212-7. PubMed ID: 21398433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Control Trial Using a Validated Prediction Model for Diagnosing Acute Heart Failure in Undifferentiated Dyspneic Emergency Department Patients-Results of the GASP4Ar Study.
    Steinhart BD; Levy P; Vandenberghe H; Moe G; Yan AT; Cohen A; Thorpe KE; McGowan M; Mazer CD
    J Card Fail; 2017 Feb; 23(2):145-152. PubMed ID: 27565045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.